UW Medicine Diabetes Institute is a clinical research site located in Seattle, Washington, United States 98109.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
UW Medicine Diabetes Institute has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Severe Hypertriglyceridemia, Metabolic Dysfunction-Associated Steatotic Liver Disease.
Sponsors: Eli Lilly and Company.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UW Medicine Diabetes Institute has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UW Medicine Diabetes Institute has 2 clinical trials on record, with 2 currently active. Their work covers Severe Hypertriglyceridemia, Metabolic Dysfunction-Associated Steatotic Liver Disease.
UW Medicine Diabetes Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.